Skip to main content
Log in

Glycated albumin modified by amadori adducts modulates aortic endothelial cell biology

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Increased protein glycation has been mechanistically linked to accelerated vascular pathobiology in diabetes. To test the influence of protein modified by Amadori glucose adducts on vascular cell biology, we examined the effect of glycated albumin on replicative capacity and basement membrane collagen production by aortic endothelial cells in culture. Relative to carbohydrate-free albumin, which supported cell proliferation and Type IV collagen synthesis, glycated albumin significantly inhibited3H-thymidine incorporation and Type IV collagen production. The glycated albumin-induced effects were prevented by monoclonal antibodies (A717) that specifically react with Amadori-modified albumin, but not by IgG that was unreactive with glycated albumin. A717 had no effect on thymidine incorporation or collagen synthesis by cells cultured in the presence of nonglycated albumin. The findings indicate that the interaction of glycated albumin with endothelial cells, which have been shown to display dose-responsive, saturable receptors, limits cell replication and triggers maladaptive biosynthetic programs, which may contribute to degenerative macrovascular disease in diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Luscher TF, Tanner FC, Tschudi MR, Noll G: Endothelial dysfunction in coronary artery disease. Annu Rev Med 44: 395–418, 1993

    Google Scholar 

  2. Nilsson J: Growth factors and the pathogenesis of atherosclerosis. Atherosclerosis 62: 185–199, 1986

    Google Scholar 

  3. Ross R: The pathogenesis of atherosclerosis: an update. New Engl J Med 314: 488–500, 1986

    Google Scholar 

  4. Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M: Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 83: 735–738 1988

    Google Scholar 

  5. Danne T, Spiro MJ, Spiro R: Effect of high glucose on Type IV collagen production by cultured glomerular epithelial, endothelial and mesangial cells. Diabetes 42: 170–177, 1992

    Google Scholar 

  6. Lorenzi M, Cagliero E, Toledo S: Glucose toxicity for human endothelial cells in culture: Delayed replication, disturbed cell cycle and accelerated death. Diabetes 34: 621–627, 1985

    Google Scholar 

  7. Lorenzi M, Nordberg JA, Toledo S: High glucose prolongs cells cycle traversal of cultured human endothelial cells. Diabetes 36: 1261–1267, 1987

    Google Scholar 

  8. Cohen MP: Ziyadeh FN: Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. Kidney Int 45: 475–484, 1994

    Google Scholar 

  9. Wu YV, Cohen MP: Identification of aortic endothelial cell binding proteins for Amadori adducts in glycated albumin. Biochem Biophys Res Comm 193: 1131–1136, 1993

    Google Scholar 

  10. Wu VY, Cohen MP: Receptors specific for Amadori-modified glycated albumin on murine endothelial cells. Biochem Biophys Res Comm 198: 734–739, 1994

    Google Scholar 

  11. Cohen MP: Diabetes and Protein Glycosylation: Measurement and Biologic Relevance. Springer Verlag, New York, 1986

    Google Scholar 

  12. Cohen MP, Hud E: Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA. J Immunolog Meth 122: 279–283, 1989

    Google Scholar 

  13. Cohen MP, Hud E: Production and characterization of monoclonal antibodies against human glycoalbumin. J Immunolog Meth 117: 121–129, 1989

    Google Scholar 

  14. Ney KA, Colley KJ, Pizzo SC: The standardization of the thiobarbituric acid assay for nonenzymatic glucosylation of human serum albumin. Anal Biochem 118: 294–300, 1981

    Google Scholar 

  15. Sell DR, Nagaraj RH, Grandee SK, Odetta P, Lapolla A, Fogarty J, Monnier V: Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia. Diabetes/Metabolism Reviews 7: 239–251, 1991

    Google Scholar 

  16. Smith PR, Thornalley PJ: Mechanism of the degradation of nonenzymatically glycated proteins under physiological conditions. Eur J Biochem 210: 729–739, 1992

    Google Scholar 

  17. Cohen MP, Hud E, Wu VY: Amelioration of diabetic nephropathy with monoclonal antibodies against glycated albumin. Kidney Int 45: 1673–1679, 1994

    Google Scholar 

  18. Gumkowski F, Kaminska G, Kaminski M, Morrissey LW, Auerbach R: Heterogeneity of mouse vascular endothelium. Blood Vessels 24: 11–23, 1987

    Google Scholar 

  19. Wolf G, Sharma L, Chen K, Ericksen M, Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kid Int 42: 647–656, 1992

    Google Scholar 

  20. Haneda M, Kikkawa R, Horide N, Togawa M, Koya D, Kajiwara N, Ooshima A, Shigeta Y: Glucose enhances Type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 34: 198–200, 1991

    Google Scholar 

  21. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP: High glucose induces cell hypertrophy and stimulates collagen gene expression in proximal tubule. Am J Physiol 259: F704–714, 1990

    Google Scholar 

  22. Ziyadeh FN, Cohen MP: Effects of glycated albumin on mesangial cells: Evidence for a role in diabetic nephropathy. Molec and Cellular Biochemistry 125: 19–25, 1993

    Google Scholar 

  23. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products and the biochemical basis of diabetic complications. New Engl J Med 318: 1315–1321, 1988

    Google Scholar 

  24. Esposito C, Gerlach H, Brent J, Stern D, Vlassara H: Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170: 1387–1407, 1989

    Google Scholar 

  25. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J et al.: Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267: 14987–14997, 1992

    Google Scholar 

  26. Silbiger S, Crowley S, Shan Z, Brownlee M, Satriano J, Schlondorff D: Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge. Kid Int 43: 853–864, 1993

    Google Scholar 

  27. Makita Z, Vlassara H, Cerami A, Bucala R: Immunochemical detection of advanced glycosylation end productsin vivo. J Biol Chem 267: 5133–5138, 1992

    Google Scholar 

  28. Crowley ST, Brownlee M, Edelstein D, Satriano JS, Mori T, Singhal PC, Schlondorff DO: Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells. Diabetes 40: 540–547, 1991

    Google Scholar 

  29. Brujin JA, Roos A, de Geus B, de Heer E: Transforming growth factor β and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 123: 34–47, 1994

    Google Scholar 

  30. Fausto N: Multifunctional roles for transforming growth factor-β1. Lab Invest 65: 497–499, 1991

    Google Scholar 

  31. Steffes MW, Bilous RW, Sutherland DER, Mauer SM: Cell and matrix components of the glomerular mesangium in Type I diabetes. Diabetes 41: 679–688, 1992

    Google Scholar 

  32. Kumazaki T, Kobayashi M, Mitsui Y: Enhanced expression of fibronectin duringin vivo cellular aging of human vascular endothelial cells and skin fibroblasts. Exper Cell Res 205: 396–402, 1993

    Google Scholar 

  33. Osterby R, Parving H-H, Hommel E, Jorgensen HE, Lokkegard H: Glomerular structure and function in diabetic nephropathy: Early to advanced stages. Diabetes 39: 1057–1063, 1990

    Google Scholar 

  34. Lorenzi M, Cagliero E: Pathobiology of endothelial and other vascular cells in diabetes mellitus. Diabetes 40: 653–659, 1991

    Google Scholar 

  35. Day JF, Ingelbretsen CG, Ingelbretsen WR, Baynes JW, Thorpe SR: Nonenzymatic glucosylation of serum proteins and hemoglobin: response to changes in blood glucose levels in diabetic rats. Diabetes 29: 524–527, 1980

    Google Scholar 

  36. Day JF, Thorpe SR, Baynes JM: Nonenzymatically glucosylated albumin:In vitro preparation and isolation from normal human serum J Biol Chem 254: 5955–5959, 1979

    Google Scholar 

  37. Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes J: Enhanced nonenzymatic glucosylation of serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 76: 4258–4261, 1979

    Google Scholar 

  38. Winocur PH, Bhatnagar D, Kalsi P, Hillier VF, Anderson DC: Relative clinical usefulness of glycosylated serum albumin and fructosamine during short-term changes in glycemic control in IDDM. Diabetes Care 12: 665–672, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cohen, M.P., Hud, E., Wu, VY. et al. Glycated albumin modified by amadori adducts modulates aortic endothelial cell biology. Mol Cell Biochem 143, 73–79 (1995). https://doi.org/10.1007/BF00925929

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00925929

Key words

Navigation